The pharmaceutical industry is embracing AI at an accelerated pace. According to news from the Chinese Academy of Information and Communications Technology on May 21, the Chinese Academy of Information and Communications Technology will join leading pharmaceutical companies, AI pharmaceutical companies, digital intelligence service companies, research institutes, regulators, industry associations and other industry players to jointly establish the “Pharmaceutical Industry Digital Intelligence Transformation Promotion Center”. The inaugural conference will be held on June 2. The global pharmaceutical industry is now at a critical turning point. The top 20 global pharmaceutical giants such as AstraZeneca, Pfizer, Johnson & Johnson, Sanofi, and Novartis have all established partnerships with AI companies. Since 2026, global pharmaceutical companies' AI cooperative transactions have reached billions of dollars. The Securities Times · Databao sorted out the core concept stocks of AI pharmaceuticals, including AI pharmaceutical platforms, CRO companies, and traditional pharmaceutical companies that actively embrace AI. There are a total of 20. In terms of performance, in the first quarter of this year, the net profit of Zhaoyan Pharmaceutical, Boji Pharmaceutical, Medici etc. increased by more than 200%, while Hongbo Pharmaceutical, Junshi Bio-U, Hanyu Pharmaceutical, and Huada Gene all increased by more than 80%. Judging from institutional research, 12 shares were surveyed by more than 10 institutions during the year. Among them, Chengdu Xiandao, Medici, Prius, and Haoyuan Pharmaceutical were all surveyed by more than 50 institutions. The above concept stocks rose by an average of nearly 5% during the year. Gloria Ying, Hongbo Pharmaceutical, Chengdu Pioneer, and Hanyu Pharmaceutical all rose by more than 20%, while Hengrui Pharmaceuticals, Huada Genomics, Tiger Pharmaceuticals, and Dongfulong all declined by more than 10%.
Zhitongcaijing · 1d ago
Share
Listen to the news
The pharmaceutical industry is embracing AI at an accelerated pace. According to news from the Chinese Academy of Information and Communications Technology on May 21, the Chinese Academy of Information and Communications Technology will join leading pharmaceutical companies, AI pharmaceutical companies, digital intelligence service companies, research institutes, regulators, industry associations and other industry players to jointly establish the “Pharmaceutical Industry Digital Intelligence Transformation Promotion Center”. The inaugural conference will be held on June 2. The global pharmaceutical industry is now at a critical turning point. The top 20 global pharmaceutical giants such as AstraZeneca, Pfizer, Johnson & Johnson, Sanofi, and Novartis have all established partnerships with AI companies. Since 2026, global pharmaceutical companies' AI cooperative transactions have reached billions of dollars. The Securities Times · Databao sorted out the core concept stocks of AI pharmaceuticals, including AI pharmaceutical platforms, CRO companies, and traditional pharmaceutical companies that actively embrace AI. There are a total of 20. In terms of performance, in the first quarter of this year, the net profit of Zhaoyan Pharmaceutical, Boji Pharmaceutical, Medici etc. increased by more than 200%, while Hongbo Pharmaceutical, Junshi Bio-U, Hanyu Pharmaceutical, and Huada Gene all increased by more than 80%. Judging from institutional research, 12 shares were surveyed by more than 10 institutions during the year. Among them, Chengdu Xiandao, Medici, Prius, and Haoyuan Pharmaceutical were all surveyed by more than 50 institutions. The above concept stocks rose by an average of nearly 5% during the year. Gloria Ying, Hongbo Pharmaceutical, Chengdu Pioneer, and Hanyu Pharmaceutical all rose by more than 20%, while Hengrui Pharmaceuticals, Huada Genomics, Tiger Pharmaceuticals, and Dongfulong all declined by more than 10%.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending